Gedunin Mitigates Cutibacterium acnes-Induced Skin Inflammation by Inhibiting the NF-κB Pathway

<b>Background/Objectives</b>: <i>Cutibacterium acnes (C. acnes)</i>, a bacterium residing in hair follicles, triggers acne by inducing monocyte-mediated inflammatory cytokine production. Gedunin, a limonoid derived from <i>Azadirachta indica</i> (commonly known as neem), is renowned for its antifungal, antimalarial, anticancer, anti-inflammatory, and neuroprotective effects. However, its role in mitigating <i>C. acnes</i>-induced skin inflammation remains unexplored. This study investigates the anti-inflammatory effects of gedunin on <i>C. acnes</i>-induced skin inflammation and elucidates the underlying mechanisms. <b>Methods</b>: The anti-inflammatory activity of gedunin was assessed using RAW 264.7 mouse macrophage cells and mouse bone-marrow-derived macrophages (BMDMs). Key inflammatory mediators, including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and interleukin-6 (IL-6), were evaluated. Mechanistic studies focused on the nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways, along with the NOD-like receptor pyrin domain-containing 3 (NLRP3) inflammasome. An in vivo acne model was employed to examine gedunin's therapeutic efficacy. <b>Results</b>: Gedunin significantly reduced the expression of IL-1β, TNF-α, iNOS, COX-2, and IL-6 in RAW 264.7 cells. It inhibited NF-κB activation without affecting the MAPK pathways, including JNK/SAPK, ERK, and p38 MAPK. Gedunin also suppressed the activation of the NLRP3 inflammasome in BMDMs. In the mouse acne model, gedunin effectively alleviated <i>C. acnes</i>-induced inflammation, primarily by targeting NF-κB signaling. <b>Conclusions</b>: Gedunin demonstrates potential as a therapeutic agent for acne treatment by targeting key inflammatory pathways, particularly NF-κB signaling. This study highlights gedunin's promise as an alternative approach to managing <i>C. acnes</i>-induced skin inflammation.

Authors

Institutions

Publication Details

Journal
Pharmaceuticals
Published
2025-01-09
DOI
https://doi.org/10.3390/ph18010071
Citations
1
Primary Topic
Acne and Rosacea Treatments and Effects
Type
article
Field-Weighted Citation Impact
2.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Gedunin Mitigates Cutibacterium acnes-Induced Skin Inflammation by Inhibiting the NF-κB Pathway

Janet Sim, Seon Sook Kim, Su Ryeon Seo, Jin Hak Shin et al.
1 citations
Pharmaceuticals
Acne and Rosacea Treatments and Effects
2.00
article

Gedunin Mitigates Cutibacterium acnes-Induced Skin Inflammation by Inhibiting the NF-κB Pathway

Janet Sim, Seon Sook Kim, Su Ryeon Seo, Jin Hak Shin, Ye Ji Heo
article en
1 citations

Abstract

<b>Background/Objectives</b>: <i>Cutibacterium acnes (C. acnes)</i>, a bacterium residing in hair follicles, triggers acne by inducing monocyte-mediated inflammatory cytokine production. Gedunin, a limonoid derived from <i>Azadirachta indica</i> (commonly known as neem), is renowned for its antifungal, antimalarial, anticancer, anti-inflammatory, and neuroprotective effects. However, its role in mitigating <i>C. acnes</i>-induced skin inflammation remains unexplored. This study investigates the anti-inflammatory effects of gedunin on <i>C. acnes</i>-induced skin inflammation and elucidates the underlying mechanisms. <b>Methods</b>: The anti-inflammatory activity of gedunin was assessed using RAW 264.7 mouse macrophage cells and mouse bone-marrow-derived macrophages (BMDMs). Key inflammatory mediators, including interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), and interleukin-6 (IL-6), were evaluated. Mechanistic studies focused on the nuclear factor-kappa B (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways, along with the NOD-like receptor pyrin domain-containing 3 (NLRP3) inflammasome. An in vivo acne model was employed to examine gedunin's therapeutic efficacy. <b>Results</b>: Gedunin significantly reduced the expression of IL-1β, TNF-α, iNOS, COX-2, and IL-6 in RAW 264.7 cells. It inhibited NF-κB activation without affecting the MAPK pathways, including JNK/SAPK, ERK, and p38 MAPK. Gedunin also suppressed the activation of the NLRP3 inflammasome in BMDMs. In the mouse acne model, gedunin effectively alleviated <i>C. acnes</i>-induced inflammation, primarily by targeting NF-κB signaling. <b>Conclusions</b>: Gedunin demonstrates potential as a therapeutic agent for acne treatment by targeting key inflammatory pathways, particularly NF-κB signaling. This study highlights gedunin's promise as an alternative approach to managing <i>C. acnes</i>-induced skin inflammation.

PharmaceuticalsVol. 18(1)
Kangwon National University (KR)
Kangwon National University, Ministry of Science and ICT, South Korea, Institute for Information and Communications Technology Promotion, Division of Human Resource Development
Good health and well-being
Openalex Percentile: Top 19%
Acne and Rosacea Treatments and Effects
2.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.